The short-term effectiveness of non-surgical treatment in reducing levels of interleukin-1β and proteases in gingival crevicular fluid from patients with type 2 diabetes mellitus and chronic periodontitis

Journal of Periodontology

Volumn 79, Issue 11, 2008, Pages 2143-2150

  Correa, Fernanda O B ^a,b   Gonçalves, Daniela ^a   Figueredo, Carlos M S ^b,c   Gustafsson, Anders ^b   Orrico, Silvana Regina Perez ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b KAROLINSKA INSTITUTE   (Sweden)

^c STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Clinical trial; Cytokines; Diabetes mellitus, type 2; Gingival crevicular fluid; Matrix metalloproteinases

Indexed keywords

GELATINASE B; INTERLEUKIN 18; INTERLEUKIN 1BETA; LEUKOCYTE ELASTASE; NEUTROPHIL COLLAGENASE; PROTEINASE;

ARTICLE; CASE CONTROL STUDY; CHRONIC PERIODONTITIS; FEMALE; GINGIVITIS; HUMAN; IMMUNOLOGY; MALE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONPARAMETRIC TEST; PERIODONTICS; PREVENTIVE DENTISTRY; REFERENCE VALUE;

CASE-CONTROL STUDIES; CHRONIC PERIODONTITIS; DENTAL SCALING; DIABETES MELLITUS, TYPE 2; ENDOPEPTIDASES; FEMALE; GINGIVAL CREVICULAR FLUID; HUMANS; INTERLEUKIN-18; INTERLEUKIN-1BETA; LEUKOCYTE ELASTASE; MALE; MATRIX METALLOPROTEINASE 8; MATRIX METALLOPROTEINASE 9; PERIODONTAL INDEX; REFERENCE VALUES; STATISTICS, NONPARAMETRIC;

EID: 55749109731     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2008.080132     Document Type: Article

References (47)

1. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989;320:365-376.
2. Chapple IL, Mason GI, Garner I, et al. Enhanced chemiluminescent assay for measuring the total antioxidant capacity of serum, saliva and crevicular fluid. Ann Clin Biochem 1997;34:412-421.
3. Papapanou PN. Periodontal diseases: Epidemiology. Ann Periodontol 1996;1:1-36.
4. Salvi GE, Yalda B, Collins JG, et al. Inflammatory mediator response as a potential risk marker for periodontal diseases in insulin-dependent diabetes mellitus patients. J Periodontol 1997;68:127-135.
5. Soskolne WA. Epidemiological and clinical aspects of periodontal disease in diabetics. Ann Periodontol 1998;3:3-12.
6. Lu HK, Yang PC. Cross-sectional analysis of different variables of patients with non-insulin dependent diabetes and their periodontal status. Int J Periodontics Restorative Dent 2004;24:71-79.
7. Campus G, Salem A, Uzzau S, Baldoni E, Tonolo G. Diabetes and periodontal disease: A case-control study. J Periodontol 2005;76:418-425.
8. Lalla E, Kaplan S, Yang J, Roth GA, Papapanou PN, Greenberg S. Effects of periodontal therapy on serum C-reactive protein, sE-selectin and tumor necrosis factor-α secretion by peripheral blood-derived macrophages in diabetes. A pilot study. J Periodontal Res 2007;42:274-282.
9. Gustafsson A, Asman B, Bergström K. Altered relation between granulocyte elastase and alpha-2-macroglobulin in gingival crevicular fluid from sites with periodontal destruction. J Clin Periodontol 1994;21:17-21.
10. Figueredo CMS, Gustafsson A. Activity and inhibition of elastase in GCF. J Clin Periodontol 1998;25:531-535.
11. Figueredo CMS, Fischer RG, Gustafsson A, Firatli E. Aberrant neutrophil reactions in periodontitis. J Periodontol 2005;76:951-955.
12. Figueredo CMS, Areas A, Miranda LA, Fischer RG, Gustafsson A. The short-effectiveness of non-surgical treatment in reducing proteases activity in gingival crevicular fluid from chronic periodontitis patients. J Clin Periodontol 2004;31:615-619.
13. Kjersem H, Hiltsted J, Madsbad S, Wandall JH, Johansen KS, Borregaard N. Polymorphonuclear leucocyte dysfunction during short-term metabolic changes from normo- to hyperglycemia type 1 (insulin dependent) diabetic patients. Infection 1988;16:215-221.
14. Alpagot T, Silverman S, Lundergan W, Bell C, Chambers DW. Crevicular fluid elastase levels in relation to periodontitis and metabolic control of diabetes. J Periodontal Res 2001;36:169-174.
15. Emingil G, Tervahartiala T, Mãntylã P, Määttä M, Sorsa T, Atilla G. Gingival crevicular fluid matrix metalloproteinase (MMP)-7, extracellular MMP inducer, and tissue inhibitor of MMP-1 levels in periodontal disease. J Periodontol 2006;77:2040-2050.
16. Safkan-Seppälä B, Sorsa T, Tervahartiala T, Beklen A, Konttinen YT. Collagenases in gingival crevicular fluid in type 1 diabetes mellitus. J Periodontol 2006;77:189-194.
17. Sorsa T, Ingman T, Suomalainen K, et al. Cellular source and tetracycline-inhibition of gingival crevicular fluid collagenase of patients with labile diabetes mellitus. J Clin Periodontol 1992;19:146-149.
18. Collin HL, Sorsa T, Meurman JH, et al. Salivary matrix metalloproteinase (MMP-8) levels and gelatinase (MMP-9) activities in patients with type 2 diabetes mellitus. J Periodontal Res 2000;35:259-265.
19. Kumar MS, Vamsi G, Sripriya R, Sehgal PK. Expression of matrix metalloproteinases (MMP-8 and -9) in chronic periodontitis patients with and without diabetes mellitus. J Periodontol 2006;77:1803-1808.
20. Engebretson SP, Hey-Hadavi J, Ehrhardt FJ, et al. Gingival crevicular fluid levels of interleukin-1b and glycemic control in patients with chronic periodontitis and type 2 diabetes. J Periodontol 2004;75:1203-1208.
21. Figueredo CM, Ribeiro MS, Fischer RG, Gustafsson A. Increased interleukin-1beta concentration in gingival crevicular fluid as a characteristic of periodontitis. J Periodontol 1999;70:1457-1463.
22. Graves DT, Cochran D. The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction. J Periodontol 2003;74:391-401.
23. Bulut U, Develioglu H, Taner IL, Berker E. Interleukin-1 beta levels in gingival crevicular fluid in type 2 diabetes mellitus and adult periodontitis. J Oral Sci 2001;43:171-177.
24. Orozco A, Gemmell E, Bickel M, Seymour GJ. Interleukin-1beta, interleukin-12 and interleukin-18 levels in gingival fluid and serum of patients with gingivitis and periodontitis. Oral Microbiol Immunol 2006;21:256-260.
25. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2008;31:S55-S60.
26. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999;4:1-6.
27. Ainamo J, Bay I. Problems and proposals for recording gingivitis and plaque. Int Dent J 1975;25:229-235.
28. Navarro-Sanchez AB, Faria-Almeida R, Bascones-Martinez A. Effect of non-surgical periodontal therapy on clinical and immunological response and glycaemic control in type 2 diabetic patients with moderate periodontitis. J Clin Periodontol 2007;34:835-843.
29. Goutoudi P, Diza E, Arvanitidou M. Effect of periodontal therapy on crevicular fluid interleukin-1β and interleukin-10 levels in chronic periodontitis. J Dent 2004;32:511-520.
30. Gamonal J, Acevedo A, Bascones A, Jorge O, Silva A. Levels of interleukin-1 beta, -8, and -10 and RANTES in gingival crevicular fluid and cell populations in adult periodontitis patients and the effect of periodontal treatment. J Periodontol 2000;71:1535-1545.
31. Kinane DF, Darby IB, Said S, et al. Changes in gingival fluid matrix metalloproteinase-8 levels during periodontal treatment and maintenance. J Periodontal Res 2003;38:400-404.
32. Cutler CW, Machen RL, Jotwani R, Iacopino AM. Heightened gingival inflammation and attachment loss in type 2 diabetics with hyperlipidemia. J Periodontol 1999;70:1313-1321.
33. Dasu MR, Devaraj S, Jialal I. High glucose induces IL-1 beta expression in human monocytes: Mechanistic insights. Am J Physiol Endocrinol Metab 2007;293:E337-E346.
34. Johnson RB, Serio FG. Interleukin-18 concentrations and the pathogenesis of periodontal disease. J Periodontol 2005;76:785-790.
35. Figueredo CM, Rescala B, Teles RP, et al. Increased interleukin-18 in gingival crevicular fluid from periodontitis patients. Oral Microbiol Immunol 2008;23:173-176.
36. Collier A, Jackson M, Bell D, et al. Neutrophil activation detected by increased neutrophil elastase activity in type 1 (insulin-dependent) diabetes mellitus. Diabetes Res 1989;10:135-138.
37. Tervonen T, Knuuttila M, Pohjamo L, Nurkkala H. Immediate response to non-surgical periodontal treatment in subjects with diabetes mellitus. J Clin Periodontol 1991;18:65-68.
38. Christgau M, Palitzsch KD, Schmalz G, Kreiner U, Frenzel S. Healing response to non-surgical periodontal therapy in patients with diabetes mellitus: Clinical, microbiological, and immunologic results. J Clin Periodontol 1998;25:112-124.
39. Westfelt E, Rylander H, Blohmé G, Jonasson P, Lindhe J. The effect of periodontal therapy in diabetics. Results after 5 years. J Clin Periodontol 1996;23:92-100.
40. Sonoki K, Nakashima S, Takata Y, et al. Decreased lipid peroxidation following periodontal therapy in type 2 diabetic patients. J Periodontol 2006;77:1907-1913.
41. Smith GT, Greenbaum CJ, Johnson BD, Rutger G. Short-term responses to periodontal therapy in insulin-dependent diabetic patients. J Periodontol 1996;67:794-802.
42. Khader YS, Dauod AS, El-Qaderi SS, Alkafajei A, Batayha WQ. Periodontal status of diabetics compared with nondiabetics: A meta-analysis. J Diabetes Complications 2006;20:59-68.
43. Bridges RB, Anderson JW, Saxe SR, Gregory K, Bridges SR. Periodontal status of diabetic and non-diabetic men: Effects of smoking, glycemic control, and socioeconomic factors. J Periodontol 1996;67:1185-1192.
44. Novaes AB Jr., Gutierrez FG, Novaes AB. Periodontal disease progression in type II non-insulin-dependent diabetes mellitus patients (NIDDM). Part I - Probing pocket depth and clinical attachment. Braz Dent J 1996;7:65-73.
45. Faria-Almeida R, Navarro A, Bascones A. Clinical and metabolic changes after conventional treatment of type 2 diabetic patients with chronic periodontitis. J Periodontol 2006;77:591-598.
46. Karjalainen KM, Knuuttila ML, Von Dickhoff KJ. Association of the severity of periodontal disease with organ complications in type 1 diabetic patients. J Periodontol 1994;65:1067-1072.
47. Syrjälä AM, Kneckt M, Knuuttila M. Dental self-efficacy as a determinant to oral health behavior, oral hygiene and HbA1c level among diabetic patients. J Clin Periodontol 1999;26:616-621.